Financhill
Back

Pacific Biosciences of California Vs. AVITA Medical Industry Stock Comparison

Sell
36

PACB
Pacific Biosciences of California

Last Price:
1.69
Seasonality Move:
-2.25%
Sell
20

RCEL
AVITA Medical

Last Price:
8.66
Seasonality Move:
-2.2%
Sell
36
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.65. The Score for PACB is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PACB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
AVITA Medical (RCEL) is a Sell

Is AVITA Medical a Buy, Sell or Hold?

  • The current AVITA Medical [RCEL] share price is $8.40. The Score for RCEL is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • RCEL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing slight selling pressure.

RCEL Stock Price Chart

What is AVITA Medical's stock price today?

  • The AVITA Medical share price today is $8.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCEL is experiencing selling pressure, which indicates risk of future bearish movement.

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.67 Sell
Relative Strength Index (14 RSI): 28.91 Sell
Chaikin Money Flow: 351964 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.59 - 3.55) Sell
Bollinger Bands (100): (3.15 - 8.25) Sell

RCEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.87 Sell
Relative Strength Index (14 RSI): 22.8 Sell
Chaikin Money Flow: -95723 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.61 - 15.05) Sell
Bollinger Bands (100): (11.78 - 17.36) Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.51 Buy
20-day SMA: 2.31 Sell
50-day SMA: 3.54 Sell
200-day SMA: 7.63 Sell
8-day EMA: 1.63 Buy
20-day EMA: 2.19 Sell
50-day EMA: 3.47 Sell
200-day EMA: 6.76 Sell

RCEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.58 Sell
20-day SMA: 10.82 Sell
50-day SMA: 14.38 Sell
200-day SMA: 14.35 Sell
8-day EMA: 8.83 Sell
20-day EMA: 10.52 Sell
50-day EMA: 12.91 Sell
200-day EMA: 13.79 Sell

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.16 per share, and an increase next year of $0.19 per share.

AVITA Medical Earnings Growth & RCEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.09 per share, an increase this year of $0.14 per share, and an increase next year of $1.09 per share.

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AVITA Medical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):